Claim: Trump's 2019 Influenza Vaccine Executive Order contains the terms DNA, mRNA etc. and Yoyo Ma the Cellist is an evil conspirator, together with others.
Dr David Martin's video seems to conflate several different quotes and documents, and in implicating Trump I think he might be unreliable. Furthermore he provides no proof re Yo-Yo Ma.
Amendment 30 October 2022 - Dr David Martin does have some of his research online.
I have been going through a document in which David Martin lists the crimes/ conflicts of interest/ contravention of Federal regulations of which Anthony Fauci is purportedly guilty. At least in this matter, David Martin’s research does appear to actually be very, very thorough.
https://www.davidmartin.world/wp-content/uploads/2021/01/The_Fauci_COVID-19_Dossier.pdf
This doesn’t alter the conclusions of this article, however, for nowhere can I find anything in his research that proves Trump was a co-conspirator.
While I honestly think Trump is an intelligent man and highly capable especially in business and management, and an effective and capable President of the US to boot (for God’s sake, China and Russia, North Korea and Iran all behaved themselves when he was President), I think certain of his comments (e.g. the ones about disinfectant cleaning the blood) suggest to me that medical knowledge is not his strong suit. Accordingly, Trump appears to have trusted Fauci.
I can also see there are videos online where Dr Martin excoriates Trump for continuing to support the vaccines.
I think Dr Martin is right to oppose the vaccines particularly for children, for they are certainly, without a doubt, ineffective at preventing Covid and most certainly harmful, killing children and maiming them.
This is the question, though - at what point does ignorance and folly become culpable? Both Trump and Yo-Yo Ma have been ignorant and foolish to support the vaccines or in the case of Yo-Yo Ma the organisations pushing the vaccines and the Great Reset - but are they liable? Are they themselves guilty?
Were they themselves part of the conspiracy to suppress the knowledge of generic treatments and push the experimental gene therapy medication (as it is described in NIH documents) as Fauci and Peter Daszak and UNITAID’s Andrew Hill and “someone high up” (the funders of UNITAID were Bill and Melinda Gates’ foundation) certainly were? Did they themselves suppress the probable origins of the virus in the Wuhan lab, as Fauci and Peter Daszak and the editor of the Lancet at the time Richard Horton certainly did?
The UK Science and Technology Select Committee conducted an inquiry in December 2021 into the origins of the Coronavirus: the first cases occurred in the Wuhan lab employees’ residential district. They interviewed the editor of the journal Lancet, Richard Horton, who confessed to ignoring and suppressing evidence of the lab leak theory.
NIH funded peer-reviewed studies conducted in the Wuhan lab going back to 2013 reveal that the they were working on gain of function. Peter Daszak, who wrote and signed the letter published in Lancet in February 2020 calling the Wuhan lab leak a conspiracy theory, was exposed as having a large conflict of interest, because his organisation Eco-Health Alliance used NIH funding to collaborate with Chinese scientists on gain of function research in the Wuhan lab.
But does any of this implicate Trump? As commander in chief, he was culpable in a sense, but did he even know any of this was going on, while he was President?
With a little more digging I also found out that Yo-Yo Ma does indeed have a seat on the World Economic Forum’s board of trustees, and he is a UN messenger for peace, and also is the chair of the committee for the Youth Music Culture Guangdong Festival in Guangzhou; in the eyes of some people this might make him a collaborator.
The big question is, again, does this really mean any more than that this man is a popular figure, being an internationally renowned Cellist, whom it is convenient for various international organisations to ask to have on their board of trustees or to chair their committees, for the purposes of publicity?
Dr Martin doesn’t prove Trump or Yo-Yo Ma are conspirators.
In Dr David Martin’s very gripping and extremely motivational speech, at the bottom of this article, he shows some quotes on the screen between 8:31 and 8:57, and makes what might be libellous claims about various public figures after this, including Trump and Yo-Yo Ma. I’d like to see proof of these things, if they are true, and Dr Martin does not provide it.
PETER DASZAK - proving a conspiracy?
The first quote is from Peter Daszak in 2015. This is certainly a true quote.
Daszak reiterated that, until an infectious disease crisis is very real, present, and at an emergency threshold, it is often largely ignored. To sustain the funding base beyond the crisis, he said, we need to increase public understanding of the need for MCMs such as a pan-influenza or pancoronavirus vaccine. A key driver is the media, and the economics follow the hype. We need to use that hype to our advantage to get to the real issues.
Investors will respond if they see profit at the end of process, Daszak stated.
This quote is from an NIH book called, “Rapid Medical Countermeasure Response to Infectious Diseases: Enabling Sustainable Capabilities Through Ongoing Public- and Private-Sector Partnerships: Workshop Summary,” it is still available online as a pdf from the NCBI NIH site here:
https://www.ncbi.nlm.nih.gov/books/NBK344339/pdf/Bookshelf_NBK344339.pdf
In the context of the book it does not seem as conspiratorial as Dr David Martin’s fast-talking emotional speech implies. It could simply apply to any future virus, and does not definitively imply planning, and is not in itself the admission of a felony of domestic terrorism.
If anything it shows that Daszak and others were definitely positioning themselves to benefit from an outbreak.
Nonetheless, Daszak is definitely heavily implicated in the creation of the coronavirus in the Wuhan lab; if this was indeed the source of the virus, but also in gain-of-function research in cooperation with the Chinese government, and this in my opinion qualifies as creating a bio-weapon, so in this assertion I think Dr Martin is correct. It is culpable; but this quote in itself is not the admission of domestic terrorism.
In a sense this is so difficult - one problem with short speeches like this is that they cannot contain all the evidence.
GPMB 2019 report - proof of a conspiracy?
The September 2019 GPMB report is found at the link below.
It contains the following section:
It is true that by September 2020, these pandemic preparedness exercises were planned, which doubtless contributed to the frenzied response to the Covid threat. Whether or not this was a deliberate conspiracy is not proven by these statements, either. But it does indicate the WHO were, again, positioning themselves to benefit from such an outrage.
Trump’s Executive Order did not contain the Text on the screen in Dr David Martin’s presentation.
Dr David Martin showed this slide, which is very confusing actually, and seems calculated to implicate Trump.
But there are a few things wrong with it.
Firstly, the quote does not come from the GPMB World at Risk pamphlet whose cover is pictured at the left, nor does it come from President Trump’s executive order which you can read for yourself; it is archived here, and I’ve printed it below.
The culprit for this quote was actually Dr Anthony Fauci, believe it or not, a few months later.
This is the quote:
In recognition of these limitations, the President signed the Executive Order on Modernizing Influenza Vaccines in the United States to Promote National Security and Public Health on September 19, 2019. Broadly, the Executive Order directs BARDA, CDC, NIH, and FDA to accelerate the adoption of improved influenza vaccine technologies. In alignment with the goals of the Executive Order, NIAID is conducting and supporting research to develop state-of-the-art vaccine platform technologies that could be used to develop universal influenza vaccines as well as to improve the speed and agility of the influenza vaccine manufacturing process. These platform technologies include, DNA, messenger RNA [MRNA], virus like S particles, vector based and self assembling nanoparticle vaccines. For example, NIAID supported scientists are investigating an mRNA vaccine candidate that would allow for a more rapid and flexible response to both seasonal and pandemic influenza than do existing vaccine production strategies.
It is actually Dr Anthony Fauci who said this, in his Testimony before the House Committee on Energy and Commerce Subcommittee on Oversight and Investigations, and here is the document:
https://docs.house.gov/meetings/IF/IF02/20191204/110278/HHRG-116-IF02-Wstate-FauciMDA-20191204.pdf
DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH
The Role of the National Institutes of Health in Research Addressing Seasonal and Pandemic Influenza
Testimony before the House Committee on Energy and Commerce Subcommittee on Oversight and Investigations
Pages 4-5 of Dr Anthony Fauci’s testimony.
When reading the Trump executive order, it is far less incriminating than the Fauci quote, and does not mention DNA, mRNA, virus like particles. Either Trump was a dupe for Fauci’s deeper plans, or Trump covered his own behind quite well. The executive order is definitely broad enough, however, to allow Fauci to do these things.
Further Misinformation in Dr Martin’s Quote
I would rather be careful of some of Dr Martin’s assertions. For all of his wonderful speeches about truth, there is a tiny bit of untruthfulness in that quote above; I wonder if you noticed it?
In the screen shot it says, “virus-like S particles”, implying that the Spike protein from Covid is mentioned in this quote from Dr Fauci.
Now, in fact, that incriminating “S” is not present in the original.
What may have happened is that when Dr Martin was copying and pasting that quote, he got the source wrong, and thought he was quoting Trump’s executive order, and furthermore, perhaps he copied it and failed to extract the page number, which is a “4” below, screenshotted from the pdf.
Perhaps when Dr David Martin cut and pasted, he pasted the “4” and seeing it there, turned it into an “S” quite innocently believing that was what it ought to be.
Lack of care, however, in such important matters, is not very comforting, when dealing with such devastating truths or untruths; whatever they are.
Addendum: it is very easy to make such a mistake - I myself did it in the above quote, calling them messenger FNA, rather than messenger RNA. Nonetheless, the “S” carries implications that are not there in the original.
The Inaccuracies in the Trump section of the video are troubling.
The assertions about Trump in Dr David Martin’s speech were troubling to me - I felt all along that Trump was Fauci’s dupe in all these things - maybe I’m wrong - and history may well show this.
But I can find no evidence at this stage that Trump had any hand in the gain of function research nor was he culpable in the gain of function/ Covid vaccine disaster other than being the dupe of the hubris and overreach of Fauci’s assurances that he could develop an mRNA vaccine “at warp speed.”
Who among us, if he or she had happened to be President, would not take the advice of the head of the NIH? Fauci seemed credible to most people at that time, and I certainly did not know about the gain of function research. Maybe Trump did, and let it continue? I don’t know. Did Trump know mRNA technology was experimental, and it normally takes 12 years of longitudinal trials to get an experimental medical treatment approved? Probably not. At the time I myself did - only because I had been researching a book about pharmaceutical companies and knew about the necessary trials to get a medication onto the market - and this was the only reason I was very suspicious of Operation Warp Speed.
And who knows; maybe some of these documents have been altered since (I checked them on archive.org, but we all know that the internet is getting less reliable; let’s hope to God that this doesn’t happen to what has been in the past a rock-solid source, archive.org )
On the basis of Dr Martin’s misleading slide, and the extra “S”, I have to worry that Dr David Martin is of the mindset that is not careful with facts, and tends to make great leaps and assumptions in the emotional heat of the moment.
Below Trump’s executive order, is Dr David Martin’s video. It is a thrilling speech, and very emotional moving, particularly when he is talking about 5 year olds getting the experimental jab, something that I also agree is dreadful and shouldn’t be happening.
Nonetheless, it’s important not to condemn people who might only have been guilty of foolishness or ignorance.
Yo-Yo Ma.
Oh - and poor old Yo-Yo Ma. I do not know why Dr David Martin is singling out Yo-Yo Ma, the famous Cellist, in this video. But considering that Dr Martin implicates Trump, unjustly, I believe, at least on the evidence Dr Martin provided, I can’t help wondering if Yo Yo Ma and some of the other people mentioned in the slide are also victims of Dr David Martin’s false assumptions.
It would be a dreadful thing to destroy someone’s reputation in a video like this, even if it is only among the proportion of the population who follows speakers like Dr Martin; who might not necessarily also listen to Yo-Yo Ma’s Cello music.
Providing the slides to your audience is one thing, Dr Martin.
How about providing a little more proof, though? We’d all like to see it, if everything you are saying is true, with documents, links, online archives if necessary. Something a little more solid.
Otherwise you’re simply ruining people’s reputations, and this is a serious matter.
Trump’s Executive Order.
Here is Trump’s Executive Order. The most I think that can be said about it is that the document was perhaps drafted by Fauci for the President to sign with enough flexibility in it to allow all the rather sinister Faustian medical advances the Doctor was drooling over.
Executive Order on Modernizing Influenza Vaccines in the United States to Promote National Security and Public Health
By the authority vested in me as President by the Constitution and the laws of the United States of America, including section 301 of title 3, United States Code, it is hereby ordered as follows:
Section 1. Findings. (a) Influenza viruses are constantly changing as they circulate globally in humans and animals. Relatively minor changes in these viruses cause annual seasonal influenza outbreaks, which result in millions of illnesses, hundreds of thousands of hospitalizations, and tens of thousands of deaths each year in the United States. Periodically, new influenza A viruses emerge from animals, including birds and pigs, that can spread efficiently and have sustained transmission among humans. This situation is called an influenza pandemic (pandemic). Unlike seasonal influenza, a pandemic has the potential to spread rapidly around the globe, infect higher numbers of people, and cause high rates of illness and death in populations that lack prior immunity. While it is not possible to predict when or how frequently a pandemic may occur, there have been 4 pandemics in the last 100 years. The most devastating pandemic occurred in 1918-1919 and is estimated to have killed more than 50 million people worldwide, including 675,000 Americans.
(b) Vaccination is the most effective defense against influenza. Despite recommendations by the Centers for Disease Control and Prevention (CDC) that nearly every American should receive the influenza vaccine annually, however, seasonal influenza vaccination levels in the United States have currently reached only about 45 percent of CDC goals.
(c) All influenza vaccines presently in use have been developed for circulating or anticipated influenza viruses. These vaccines must be reformulated for each influenza season as well as in the event of a pandemic. Additional research is needed to develop influenza vaccines that provide more effective and longer-lasting protection against many or all influenza viruses.
(d) The current domestic enterprise for manufacturing influenza vaccines has critical shortcomings. Most influenza vaccines are made in chicken eggs, using a 70-year-old process that requires months-long production timelines, limiting their utility for pandemic control; rely on a potentially vulnerable supply chain of eggs; require the use of vaccine viruses adapted for growth in eggs, which could introduce mutations of the influenza vaccine virus that may render the final product less effective; and are unsuitable for efficient and scalable continuous manufacturing platforms.
(e) The seasonal influenza vaccine market rewards manufacturers that deliver vaccines in time for the influenza season, without consideration of the speed or scale of these manufacturers’ production processes. This approach is insufficient to meet the response needs in the event of a pandemic, which can emerge rapidly and with little warning. Because the market does not sufficiently reward speed, and because a pandemic has the potential to overwhelm or compromise essential government functions, including defense and homeland security, the Government must take action to promote faster and more scalable manufacturing platforms.
Sec. 2. Policy. It is the policy of the United States to modernize the domestic influenza vaccine enterprise to be highly responsive, flexible, scalable, and more effective at preventing the spread of influenza viruses. This is a public health and national security priority, as influenza has the potential to significantly harm the United States and our interests, including through large-scale illness and death, disruption to military operations, and damage to the economy. This order directs actions to reduce the United States’ reliance on egg-based influenza vaccine production; to expand domestic capacity of alternative methods that allow more agile and rapid responses to emerging influenza viruses; to advance the development of new, broadly protective vaccine candidates that provide more effective and longer lasting immunities; and to support the promotion of increased influenza vaccine immunization across recommended populations.
Sec. 3. National Influenza Vaccine Task Force. (a) There is hereby established a National Influenza Vaccine Task Force (Task Force). The Task Force shall identify actions to achieve the objectives identified in section 2 of this order and monitor and report on the implementation and results of those actions. The Task Force shall be co-chaired by the Secretary of Defense and the Secretary of Health and Human Services, or their designees.
(b) In addition to the Co-Chairs, the Task Force shall consist of a senior official from the following executive branch departments, agencies, and offices:
(i) the Department of Defense (DOD);
(ii) the Department of Justice;
(iii) the Department of Agriculture;
(iv) the Department of Veterans Affairs (VA);
(v) the Department of Homeland Security;
(vi) the United States Food and Drug Administration;
(vii) the Centers for Disease Control and Prevention;
(viii) the National Institutes of Health (NIH);
(ix) the Centers for Medicare and Medicaid Services (CMS); and
(x) the Biomedical Advanced Research and Development Authority (BARDA).
(c) The Co-Chairs may jointly invite additional Federal Government representatives, with the consent of the applicable executive department, agency, or office head, to attend meetings of the Task Force or to become members of the Task Force, as appropriate.
(d) The staffs of the Department of State, the Office of Management and Budget (OMB), the National Security Council, the Council of Economic Advisers, the Domestic Policy Council, the National Economic Council, and the Office of Science and Technology Policy (OSTP) may attend and participate in any Task Force meetings or discussions.
(e) The Task Force may consult with State, local, tribal, and territorial government officials and private sector representatives, as appropriate and consistent with applicable law.
(f) Within 120 days of the date of this order, the Task Force shall submit a report to the President, through the Assistant to the President for National Security Affairs, the Assistant to the President for Domestic Policy, the Director of the Office of Management and Budget, and the Director of the Office of Science and Technology Policy. The report shall include:
(i) a 5-year national plan (Plan) to promote the use of more agile and scalable vaccine manufacturing technologies and to accelerate development of vaccines that protect against many or all influenza viruses;
(ii) recommendations for encouraging non-profit, academic, and private-sector influenza vaccine innovation; and
(iii) recommendations for increasing influenza vaccination among the populations recommended by the CDC and for improving public understanding of influenza risk and informed influenza vaccine decision-making.
(g) Not later than June 1 of each of the 5 years following submission of the report described in subsection (f) of this section, the Task Force shall submit an update on implementation of the Plan and, as appropriate, new recommendations for achieving the policy objectives set forth in section 2 of this order.
Sec. 4. Agency Implementation. The heads of executive departments and agencies shall also implement the policy objectives defined in section 2 of this order, consistent with existing authorities and appropriations, as follows:
(a) The Secretary of HHS shall:
(i) through the Assistant Secretary for Preparedness and Response and BARDA:
(A) estimate the cost of expanding and diversifying domestic vaccine-manufacturing capacity to use innovative, faster, and more scalable technologies, including cell-based and recombinant vaccine manufacturing, through cost-sharing agreements with the private sector, which shall include an agreed-upon pricing strategy during a pandemic;
(B) estimate the cost of expanding domestic production capacity of adjuvants in order to combine such adjuvants with both seasonal and pandemic influenza vaccines;
(C) estimate the cost of expanding domestic fill-and-finish capacity to rapidly fulfill antigen and adjuvant needs for pandemic response;
(D) estimate the cost of developing, evaluating, and implementing delivery systems to augment limited supplies of needles and syringes and to enable the rapid and large-scale administration of pandemic influenza vaccines;
(E) evaluate incentives for the development and production of vaccines by private manufacturers and public-private partnerships, including, in emergency situations, the transfer of technology to public-private partnerships — such as the HHS Centers for Innovation and Advanced Development and Manufacturing or other domestic manufacturing facilities — in advance of a pandemic, in order to be able to ensure adequate domestic pandemic manufacturing capacity and capability;
(F) support, in coordination with the DOD, NIH, and VA, a suite of clinical studies featuring different adjuvants to support development of improved vaccines and further expand vaccine supply by reducing the dose of antigen required; and
(G) update, in coordination with other relevant public health agencies, the research agenda to dramatically improve the effectiveness, efficiency, and reliability of influenza vaccine production;
(ii) through the Director of NIH, provide to the Task Force estimated timelines for implementing NIH’s strategic plan and research agenda for developing influenza vaccines that can protect individuals over many years against multiple types of influenza viruses;
(iii) through the Commissioner of Food and Drugs:
(A) further implement vaccine production process improvements to reduce the time required for vaccine production (e.g., through the use of novel technologies for vaccine seed virus development and through implementation of improved potency and sterility assays);
(B) develop, in conjunction with the CDC, proposed alternatives for the timing of vaccine virus selection to account for potentially shorter timeframes associated with non egg based manufacturing and to facilitate vaccines optimally matched to the circulating strains;
(C) further support the conduct, in collaboration with the DOD, BARDA, and CDC, of applied scientific research regarding developing cell lines and expression systems that markedly increase the yield of cell-based and recombinant influenza vaccine manufacturing processes; and
(D) assess, in coordination with BARDA and relevant vaccine manufacturers, the use and potential effects of using advanced manufacturing platforms for influenza vaccines;
(iv) through the Director of the CDC:
(A) expand vaccine effectiveness studies to more rapidly evaluate the effectiveness of cell based and recombinant influenza vaccines relative to egg-based vaccines;
(B) explore options to expand the production capacity of cell-based vaccine candidates used by industry;
(C) develop a plan to expand domestic capacity for whole genome characterization of influenza viruses;
(D) increase influenza vaccine use through enhanced communication and by removing barriers to vaccination; and
(E) enhance communication to healthcare providers about the performance of influenza vaccines, in order to assist them in promoting the most effective vaccines for their patient populations; and
(v) through the Administrator of CMS, examine the current legal, regulatory, and policy framework surrounding payment for influenza vaccines and assess adoption of domestically manufactured vaccines that have positive attributes for pandemic response (such as scalability and speed of manufacturing).
(b) The Secretary of Defense shall:
(i) provide OMB with a cost estimate for transitioning DOD’s annual procurement of influenza vaccines to vaccines manufactured both domestically and through faster, more scalable, and innovative technologies;
(ii) direct, in coordination with the VA, CDC, and other components of HHS, the conduct of epidemiological studies of vaccine effectiveness to improve knowledge of the clinical effect of the currently licensed influenza vaccines;
(iii) use DOD’s network of clinical research sites to evaluate the effectiveness of licensed influenza vaccines, including methods of boosting their effectiveness;
(iv) identify opportunities to use DOD’s vaccine research and development enterprise, in collaboration with HHS, to include both early discovery and design of influenza vaccines as well as later-stage evaluation of candidate influenza vaccines;
(v) investigate, in collaboration with HHS, alternative correlates of immune protection that could facilitate development of next-generation influenza vaccines;
(vi) direct the conduct of a study to assess the feasibility of using DOD’s advanced manufacturing facility for manufacturing cell-based or recombinant influenza vaccines during a pandemic; and
(vii) accelerate, in collaboration with HHS, research regarding rapidly scalable prophylactic influenza antibody approaches to complement a universal vaccine initiative and address gaps in current vaccine coverage.
(c) The Secretary of VA shall provide OMB with a cost estimate for transitioning its annual procurement of influenza vaccines to vaccines manufactured both domestically and with faster, more scalable, and innovative technologies.
Sec. 5. Termination. The Task Force shall terminate upon direction from the President or, with the approval of the President, upon direction from the Task Force Co-Chairs.
Sec. 6. General Provisions. (a) Nothing in this order shall be construed to impair or otherwise affect:
(i) the authority granted by law to an executive department or agency, or the head thereof; or
(ii) the functions of the Director of the Office of Management and Budget relating to budgetary, administrative, or legislative proposals.
(b) This order shall be implemented consistent with applicable law and subject to the availability of appropriations.
(c) This order is not intended to, and does not, create any right or benefit, substantive or procedural, enforceable at law or in equity by any party against the United States, its departments, agencies, or entities, its officers, employees, or agents, or any other person.
DONALD J. TRUMP
THE WHITE HOUSE,
September 19, 2019.
CHANGE LOG
30 Oct 2022 added the first section Amendment 30 October 2022 - Dr David Martin does have some of his research online, and deleted the paragraph with the Biblical quote Luke 16:10 and the plea for correction from my readers. But if you do find something untrue here, please put it in the comments!
Did you know that Trump's second wife, Marla, had Lyme disease? and that she found her cure through 'disinfecting' the blood with Ozone Therapy with the help of Dr Howard Robins MD? Clearly medical issues are not Trump's forte but he does not say things that he does not know about.. Why didn't Trump expand on this? Because he likely understood that it would destroy this physician's practice... just like they destroyed HCQ access to the public.